{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T21:33:36Z","timestamp":1777325616508,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR076978"],"award-info":[{"award-number":["R01AR076978"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R90DE023059"],"award-info":[{"award-number":["R90DE023059"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011130","name":"University of Maine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtn.2025.102683","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T23:40:22Z","timestamp":1755128422000},"page":"102683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epigenetic small molecule screening identifies a new HDACi compound for ameliorating Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"36","author":[{"given":"Ke\u2019ale W.","family":"Louie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva H.","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Gist H.","family":"Farr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda C.","family":"Ignacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Paguio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Maenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison G.","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa A.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-790X","authenticated-orcid":false,"given":"Lisa","family":"Maves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102683_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102683_bib2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/328434a0","article-title":"A cDNA clone from the Duchenne\/Becker muscular dystrophy gene","volume":"328","author":"Burghes","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102683_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtn.2025.102683_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130544","article-title":"A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy","volume":"264","author":"Elasbali","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.omtn.2025.102683_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy","volume":"96","author":"Allen","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.omtn.2025.102683_bib6","first-page":"11856","article-title":"Cellular pathogenesis of Duchenne muscular dystrophy: progressive myofibre degeneration, chronic inflammation, reactive myofibrosis and satellite cell dysfunction","volume":"33","author":"Dowling","year":"2023","journal-title":"Eur. J. Transl. Myol."},{"key":"10.1016\/j.omtn.2025.102683_bib7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3233\/JND-230219","article-title":"Draft guidance for industry Duchenne muscular dystrophy, Becker muscular dystrophy, and related dystrophinopathies\u2013developing potential treatments for the entire spectrum of disease","volume":"11","author":"McDonald","year":"2024","journal-title":"JND"},{"key":"10.1016\/j.omtn.2025.102683_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2025.102683_bib9","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s13311-023-01423-y","article-title":"Evolving therapeutic options for the treatment of Duchenne muscular dystrophy","volume":"20","author":"D\u2019Ambrosio","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omtn.2025.102683_bib10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/14737175.2023.2249607","article-title":"Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments","volume":"23","author":"Happi Mbakam","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.omtn.2025.102683_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/hum.2023.053","article-title":"CRISPR-editing therapy for Duchenne muscular dystrophy","volume":"34","author":"Chemello","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102683_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/hum.2023.026","article-title":"The future of exon skipping for Duchenne muscular dystrophy","volume":"34","author":"Aartsma-Rus","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102683_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/21678707.2016.1240613","article-title":"Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy","volume":"4","author":"Spinazzola","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.omtn.2025.102683_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.950651","article-title":"Drug development progress in Duchenne muscular dystrophy","volume":"13","author":"Deng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102683_bib15","article-title":"Epigenetic regulators modulate muscle damage in Duchenne muscular dystrophy model","volume":"9","author":"Bajanca","year":"2017","journal-title":"PLoS Curr."},{"key":"10.1016\/j.omtn.2025.102683_bib16","article-title":"The HDAC inhibitor TSA ameliorates a zebrafish model of Duchenne muscular dystrophy","volume":"5","author":"Johnson","year":"2013","journal-title":"PLoS Curr."},{"key":"10.1016\/j.omtn.2025.102683_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13395-020-00251-4","article-title":"A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy","volume":"10","author":"Farr","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtn.2025.102683_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105750","article-title":"Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy","volume":"170","author":"Spreafico","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.omtn.2025.102683_bib19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm1479","article-title":"Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors","volume":"12","author":"Minetti","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102683_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2119\/molmed.2013.00011","article-title":"Preclinical studies in the Mdx mouse model of Duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat","volume":"19","author":"Consalvi","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.omtn.2025.102683_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.nmd.2016.07.002","article-title":"Histological effects of givinostat in boys with Duchenne muscular dystrophy","volume":"26","author":"Bettica","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2025.102683_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1474-4422(24)00036-X","article-title":"Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Mercuri","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2025.102683_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.molmed.2024.01.007","article-title":"HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients","volume":"30","author":"Mozzetta","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtn.2025.102683_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1242\/dev.123.1.399","article-title":"Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva","volume":"123","author":"Granato","year":"1996","journal-title":"Development"},{"key":"10.1016\/j.omtn.2025.102683_bib25","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1242\/dev.00799","article-title":"Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo","volume":"130","author":"Bassett","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.omtn.2025.102683_bib26","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ddtec.2012.03.001","article-title":"Zebrafish based small molecule screens for novel DMD drugs","volume":"10","author":"Kawahara","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.omtn.2025.102683_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17460441.2020.1718100","article-title":"Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine","volume":"15","author":"Wasala","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102683_bib28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.nmd.2010.08.004","article-title":"Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology","volume":"20","author":"Berger","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2025.102683_bib29","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1073\/pnas.1102116108","article-title":"Drug screening in a zebrafish model of Duchenne muscular dystrophy","volume":"108","author":"Kawahara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102683_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/genetics\/iyac016","article-title":"Zebrafish information network, the knowledgebase for Danio Rerio research","volume":"220","author":"Bradford","year":"2022","journal-title":"Genetics"},{"key":"10.1016\/j.omtn.2025.102683_bib30","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1093\/hmg\/ddu185","article-title":"Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy","volume":"23","author":"Waugh","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102683_bib31","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/hmg\/ddt579","article-title":"Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling","volume":"23","author":"Kawahara","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102683_bib32","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/sj.onc.1202564","article-title":"Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase","volume":"18","author":"Kim","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2025.102683_bib33","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1073\/pnas.112218599","article-title":"Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases","volume":"99","author":"Iezzi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102683_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1534-5807(04)00107-8","article-title":"Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin","volume":"6","author":"Iezzi","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omtn.2025.102683_bib35","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202254721","article-title":"Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro-adipogenic progenitors","volume":"23","author":"Consalvi","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omtn.2025.102683_bib36","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050339","article-title":"Standardization of zebrafish drug testing parameters for muscle diseases","volume":"17","author":"Karuppasamy","year":"2024","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtn.2025.102683_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JND-190389","article-title":"Discovery of novel therapeutics for muscular dystrophies using zebrafish phenotypic screens","volume":"6","author":"Widrick","year":"2019","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtn.2025.102683_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","article-title":"Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials","volume":"20","author":"Patton","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102683_bib39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/ph14060500","article-title":"Zebrafish, an in vivo platform to screen drugs and proteins for biomedical use","volume":"14","author":"Lee","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.omtn.2025.102683_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fphar.2019.00508","article-title":"Orthogonal drug pooling enhances phenotype-based discovery of ocular antiangiogenic drugs in zebrafish larvae","volume":"10","author":"Ohnesorge","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102683_bib41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/emmm.201202096","article-title":"Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old mdx mice","volume":"5","author":"Mozzetta","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2025.102683_bib42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1101\/gad.234468.113","article-title":"HDAC-regulated myomirs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles","volume":"28","author":"Saccone","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2025.102683_bib43","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.3390\/ijms24054306","article-title":"Histone deacetylases: molecular mechanisms and therapeutic implications for muscular dystrophies","volume":"24","author":"Sandon\u00e0","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.omtn.2025.102683_bib44","doi-asserted-by":"crossref","first-page":"19183","DOI":"10.1073\/pnas.0805514105","article-title":"HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment","volume":"105","author":"Colussi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102683_bib45","doi-asserted-by":"crossref","first-page":"e01815-20","DOI":"10.1128\/AAC.01815-20","article-title":"Epigenetic compound screening uncovers small molecules for reactivation of latent HIV-1","volume":"65","author":"Zutz","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2025.102683_bib46","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1038\/s41467-022-34831-3","article-title":"Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-\u03b2 via Smad3 acetylation","volume":"13","author":"Osseni","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102683_bib47","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1021\/acsmedchemlett.9b00287","article-title":"Fluorinated analogues of the histone deacetylase inhibitor vorinostat (zolinza): validation of a chiral hybrid bioisostere, BITE","volume":"10","author":"Erdeljac","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.omtn.2025.102683_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111672","article-title":"A fluorine scan on the Zn2+-binding thiolate side chain of HDAC inhibitor largazole: synthesis, biological evaluation, and molecular modeling","volume":"182","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.omtn.2025.102683_bib49","series-title":"The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio)","author":"Westerfield","year":"2007"},{"key":"10.1016\/j.omtn.2025.102683_bib50","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1111\/j.1582-4934.2011.01260.x","article-title":"Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafish","volume":"15","author":"Berger","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.omtn.2025.102683_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00018-021-04066-4","article-title":"Sexual determination in zebrafish","volume":"79","author":"Aharon","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omtn.2025.102683_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jdb11020016","article-title":"Comparison of pronase versus manual dechorionation of zebrafish embryos for small molecule treatments","volume":"11","author":"Hasegawa","year":"2023","journal-title":"JDB"},{"key":"10.1016\/j.omtn.2025.102683_bib53","article-title":"Analysis of skeletal muscle defects in larval zebrafish by birefringence and touch-evoke escape response assays","volume":"82","author":"Smith","year":"2013","journal-title":"JoVE J."},{"key":"10.1016\/j.omtn.2025.102683_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","article-title":"Sample size determination and power analysis using the G\u2217Power software","volume":"18","author":"Kang","year":"2021","journal-title":"J. Educ. Eval. Health Prof."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125002379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125002379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:40:13Z","timestamp":1777322413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125002379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2162253125002379"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102683","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.24.634796","asserted-by":"object"}]},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic small molecule screening identifies a new HDACi compound for ameliorating Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102683"}}